Synovus Financial’s SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$507K Sell
6,107
-389
-6% -$32.3K 0.01% 662
2025
Q1
$527K Sell
6,496
-94
-1% -$7.63K 0.01% 644
2024
Q4
$594K Sell
6,590
-2,801
-30% -$252K 0.01% 596
2024
Q3
$928K Buy
9,391
+4,939
+111% +$488K 0.01% 527
2024
Q2
$413K Sell
4,452
-247
-5% -$22.9K 0.01% 661
2024
Q1
$446K Buy
4,699
+90
+2% +$8.54K 0.01% 645
2023
Q4
$412K Sell
4,609
-409
-8% -$36.5K 0.01% 652
2023
Q3
$366K Buy
5,018
+429
+9% +$31.3K ﹤0.01% 689
2023
Q2
$382K Sell
4,589
-669
-13% -$55.7K ﹤0.01% 678
2023
Q1
$401K Buy
5,258
+264
+5% +$20.1K ﹤0.01% 661
2022
Q4
$415K Sell
4,994
-4,708
-49% -$391K ﹤0.01% 656
2022
Q3
$771K Buy
9,702
+1,098
+13% +$87.3K 0.01% 482
2022
Q2
$639K Sell
8,604
-6,858
-44% -$509K 0.01% 525
2022
Q1
$1.39M Buy
15,462
+13,116
+559% +$1.18M 0.01% 390
2021
Q4
$264K Buy
+2,346
New +$264K ﹤0.01% 772
2020
Q3
Sell
-604
Closed -$68K 1476
2020
Q2
$68K Sell
604
-963
-61% -$108K ﹤0.01% 846
2020
Q1
$122K Buy
1,567
+780
+99% +$60.7K ﹤0.01% 871
2019
Q4
$75K Sell
787
-363
-32% -$34.6K ﹤0.01% 866
2019
Q3
$89K Hold
1,150
﹤0.01% 797
2019
Q2
$101K Hold
1,150
﹤0.01% 704
2019
Q1
$104K Sell
1,150
-37
-3% -$3.35K ﹤0.01% 694
2018
Q4
$86K Sell
1,187
-82
-6% -$5.94K ﹤0.01% 704
2018
Q3
$122K Buy
1,269
+127
+11% +$12.2K ﹤0.01% 680
2018
Q2
$109K Hold
1,142
﹤0.01% 673
2018
Q1
$99K Buy
+1,142
New +$99K ﹤0.01% 676
2017
Q3
Sell
-152
Closed -$12K 760
2017
Q2
$12K Hold
152
﹤0.01% 727
2017
Q1
$10K Buy
+152
New +$10K ﹤0.01% 954